Mouri A - Search Results

1

Cerebellar α₆ -subunit-containing GABA_A receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

Chiou LC, Lee HJ, Ernst M, Huang WJ, Chou JF, Chen HL, Mouri A, Chen LC, Treven M, Mamiya T, Fan PC, Knutson DE, Witzigmann C, Cook J, Sieghart W, Nabeshima T. Chiou LC, et al. Among authors: mouri a. Br J Pharmacol. 2018 Jun;175(12):2414-2427. doi: 10.1111/bph.14198. Epub 2018 May 10. Br J Pharmacol. 2018. PMID: 29518821 Free PMC article.

2

Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine.

Enomoto T, Noda Y, Mouri A, Shin EJ, Wang D, Murai R, Hotta K, Furukawa H, Nitta A, Kim HC, Nabeshima T. Enomoto T, et al. Among authors: mouri a. Mol Pharmacol. 2005 Dec;68(6):1765-74. doi: 10.1124/mol.105.011304. Epub 2005 Sep 8. Mol Pharmacol. 2005. PMID: 16150934

3

Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.

Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T. Mouri A, et al. Behav Brain Res. 2006 Mar 15;168(1):83-91. doi: 10.1016/j.bbr.2005.10.014. Epub 2005 Dec 19. Behav Brain Res. 2006. PMID: 16360221

4

Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory.

Zou LB, Mouri A, Iwata N, Saido TC, Wang D, Wang MW, Mizoguchi H, Noda Y, Nabeshima T. Zou LB, et al. Among authors: mouri a. J Pharmacol Exp Ther. 2006 Apr;317(1):334-40. doi: 10.1124/jpet.105.095687. Epub 2005 Dec 28. J Pharmacol Exp Ther. 2006. PMID: 16382024

5

[Dysfunction of glutamatergic systems and potential animal models of schizophrenia].

Mouri A, Noda Y, Mizoguchi H, Nabeshima T. Mouri A, et al. Nihon Yakurigaku Zasshi. 2006 Jan;127(1):4-8. doi: 10.1254/fpj.127.4. Nihon Yakurigaku Zasshi. 2006. PMID: 16508216 Review. Japanese. No abstract available.

6

An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway.

Cen X, Nitta A, Ohya S, Zhao Y, Ozawa N, Mouri A, Ibi D, Wang L, Suzuki M, Saito K, Ito Y, Kawagoe T, Noda Y, Ito Y, Furukawa S, Nabeshima T. Cen X, et al. Among authors: mouri a. J Neurosci. 2006 Mar 22;26(12):3335-44. doi: 10.1523/JNEUROSCI.5010-05.2006. J Neurosci. 2006. PMID: 16554484 Free PMC article.

7

The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.

Wang D, Noda Y, Zhou Y, Mouri A, Mizoguchi H, Nitta A, Chen W, Nabeshima T. Wang D, et al. Among authors: mouri a. Neuropsychopharmacology. 2007 Jun;32(6):1261-71. doi: 10.1038/sj.npp.1301256. Epub 2006 Nov 29. Neuropsychopharmacology. 2007. PMID: 17133263

8

Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.

Nabeshima T, Mouri A, Murai R, Noda Y. Nabeshima T, et al. Among authors: mouri a. Ann N Y Acad Sci. 2006 Nov;1086:160-8. doi: 10.1196/annals.1377.003. Ann N Y Acad Sci. 2006. PMID: 17185514 Review.

9

Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.

Mouri A, Noda Y, Hara H, Mizoguchi H, Tabira T, Nabeshima T. Mouri A, et al. FASEB J. 2007 Jul;21(9):2135-48. doi: 10.1096/fj.06-7685com. Epub 2007 Mar 6. FASEB J. 2007. PMID: 17341681

10

Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.

Mouri A, Noda Y, Noda A, Nakamura T, Tokura T, Yura Y, Nitta A, Furukawa H, Nabeshima T. Mouri A, et al. Mol Pharmacol. 2007 Jun;71(6):1598-609. doi: 10.1124/mol.106.032961. Epub 2007 Mar 7. Mol Pharmacol. 2007. PMID: 17344353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page